Barclays PLC Biotechnology

Barclays PLC

  • $436 Billion
  • Q2 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
NVO
Novo Nordisk A S
PUT
$17.3 Million
250K
Q2 2025
Added 48.25%
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$14.2 Million
392K
Q2 2025
Added 25.01%
BPMC
Blueprint Medicines Corp
CALL
$12.2 Million
95.3K
Q2 2025
Added 1101.37%
RCUS
Arcus Biosciences, Inc.
CALL
$10.3 Million
1.27M
Q2 2025
Added 34.99%
MRNA
Moderna, Inc.
PUT
$5.69 Million
206K
Q2 2025
Added 53.62%
NVO
Novo Nordisk A S
CALL
$5.2 Million
75.3K
Q2 2025
Added 48.25%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$4.21 Million
13.9K
Q2 2025
Added 33.72%
BNTX
Bio N Tech Se
PUT
$3.19 Million
30K
Q2 2025
Reduced 78.9%
CRSP
Crispr Therapeutics Ag
PUT
$3.06 Million
63K
Q2 2025
Added 324.68%
IONS
Ionis Pharmaceuticals Inc
PUT
$2.39 Million
60.6K
Q2 2025
Added 64.79%
SRPT
Sarepta Therapeutics, Inc.
CALL
$1.92 Million
112K
Q2 2025
Reduced 7.66%
VRTX
Vertex Pharmaceuticals Inc
PUT
$1.78 Million
4K
Q2 2025
Reduced 0.36%
ARQT
Arcutis Biotherapeutics, Inc.
CALL
$1.56 Million
112K
Q2 2025
Added 102.31%
QURE
Uni Qure N.V.
PUT
$1.39 Million
100K
Q2 2025
Added 31.4%
BMRN
Biomarin Pharmaceutical Inc
CALL
$978,000
17.8K
Q2 2025
Added 64.74%
CAPR
Capricor Therapeutics, Inc.
PUT
$934,000
94.1K
Q2 2025
Added 68.81%
NUVL
Nuvalent, Inc.
CALL
$824,000
10.8K
Q2 2025
Added 55.78%
CORT
Corcept Therapeutics Inc
PUT
$771,000
10.5K
Q2 2025
Reduced 53.06%
MRUS
Merus N.V.
CALL
$768,000
14.6K
Q2 2025
Added 12.38%
REPL
Replimune Group, Inc.
CALL
$705,000
75.9K
Q2 2025
Added 140.39%
SRPT
Sarepta Therapeutics, Inc.
PUT
$684,000
40K
Q2 2025
Reduced 7.66%
FOLD
Amicus Therapeutics, Inc.
PUT
$653,000
114K
Q2 2025
Added 85.94%
KALV
Kal Vista Pharmaceuticals, Inc.
CALL
$574,000
50.8K
Q2 2025
Added 205.87%
COGT
Cogent Biosciences, Inc.
CALL
$567,000
79K
Q2 2025
Added 83.27%
PTCT
Ptc Therapeutics, Inc.
CALL
$484,000
9.9K
Q2 2025
Added 111.44%
MLTX
Moon Lake Immunotherapeutics
CALL
$472,000
10K
Q2 2025
Reduced 76.77%
TVTX
Travere Therapeutics, Inc.
CALL
$444,000
30K
Q2 2025
Reduced 35.69%
IONS
Ionis Pharmaceuticals Inc
CALL
$419,000
10.6K
Q2 2025
Added 64.79%
IBRX
Immunity Bio, Inc.
PUT
$317,000
120K
Q2 2025
Added 130.09%
LQDA
Liquidia Corp
PUT
$273,000
21.9K
Q2 2025
Added 84.56%
FOLD
Amicus Therapeutics, Inc.
CALL
$186,000
32.4K
Q2 2025
Added 85.94%
RGNX
Regenxbio Inc.
PUT
$176,000
21.4K
Q2 2025
Added 100.18%
RGNX
Regenxbio Inc.
CALL
$176,000
21.4K
Q2 2025
Added 100.18%
MRNA
Moderna, Inc.
CALL
$33,000
1.2K
Q2 2025
Added 53.62%
CYTK
Cytokinetics Inc
CALL
$7,000
200
Q2 2025
Added 59.23%
CYTK
Cytokinetics Inc
PUT
$7,000
200
Q2 2025
Added 59.23%
Filter Shares Options
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email